Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices 29771 

research who are invited by the Agency 

for Healthcare Research and Quality 

(AHRQ), and agree to be available, to 

conduct on an as needed basis, 

scientific reviews of applications for 

AHRQ support. Individual members of 

the Panel do not attend regularlyscheduled meetings and do not serve for 

fixed terms or a long period of time. 

Rather, they are asked to participate in 

particular review meetings which 

require their type of expertise. 

Substantial segments of the upcoming 

SEP meeting listed below will be closed 

to the public in accordance with the 

Federal Advisory Committee Act, 

section 10(d) of 5 U.S.C., Appendix 2 

and 5 U.S.C. 552b(c)(6). Grant 

applications for the OS ARRA: Scalable 

Distributed Networks in CE (R01) 

applications are to be reviewed and 

discussed at this meeting. These 

discussions are likely to reveal personal 

information concerning individuals 

associated with the applications. This 

information is exempt from mandatory 

disclosure under the above-cited 

statutes. 

SEP Meeting on: OS ARRA: Scalable 

Distributed Networks in CE (R01). 

Dates: June 24, 2010 (Open on June 24 

from 1 p.m. to 1:15 p.m. and closed for the 

remainder of the meeting.) 

Place: Hilton Rockville Executive Meeting 

Center, 1750 Rockville Pike, Conference 

Room TBD, Rockville, MD 20852. 

Contact Person: Anyone wishing to obtain 

a roster of members, agenda or minutes of the 

nonconfidential portions of this meeting 

should contact Mrs. Bonnie Campbell, 

Committee Management Officer, Office of 

Extramural Research, Education and Priority 

Populations, AHRQ, 540 Gaither Road, Room 

2038, Rockville, Maryland 20850, Telephone 

(301) 427–1554. 

Agenda items for this meeting are subject 

to change as priorities dictate. 

Dated: May 13, 2010. 

Carolyn M. Clancy, 

Director. 

[FR Doc. 2010–12542 Filed 5–26–10; 8:45 am] 

BILLING CODE 4160–90–M 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Center for Scientific Review; Notice of 

Closed Meetings 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of the following meetings. 

The meetings will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Medical Imaging. 

Date: June 21–22, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: The Dupont Hotel, 1500 New 

Hampshire Avenue, NW., Washington, DC 

20036. 

Contact Person: Leonid V. Tsap, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5128, 

MSC 7854, Bethesda, MD 20892, (301) 435– 

2507, tsapl@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-HIV Diagnostics, Food Safety, 

Sterilization/Disinfection and 

Bioremediation. 

Date: June 21–22, 2010. 

Time: 8:30 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hotel Kabuki, 1625 Post Street, San 

Francisco, CA 94115. 

Contact Person: John C. Pugh, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3114, 

MSC 7808, Bethesda, MD 20892, (301) 435– 

2398, pughjohn@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Developmental Biology and Aging. 

Date: June 21–22, 2010. 

Time: 2 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Paek-Gyu Lee, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4201, 

MSC 7812, Bethesda, MD 20892, (301) 435– 

1277, leepg@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Chronic 

Fatigue Syndrome, Fibromyalgia Syndrome, 

and Temporomandibular Disorders. 

Date: June 22–23, 2010. 

Time: 7 a.m. to 6 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 

Contact Person: Lynn E. Luethke, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5166, 

MSC 7844, Bethesda, MD 20892, (301) 806– 

3323, luethkel@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; PAR–10– 

018: Accelerating the Pace of Drug Abuse 

Research Using Existing Epidemiology, 

Prevention, and Treatment Research Data. 

Date: June 22, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Elisabeth Koss, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3139, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

1721, kosse@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Population 

Science and Epidemiology PAR. 

Date: June 22, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Embassy Suites at the Chevy Chase 

Pavilion, 4300 Military Road, NW., 

Washington, DC 20015. 

Contact Person: Bob Weller, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3160, 

MSC 7770, Bethesda, MD 20892, (301) 435– 

0694, wellerr@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Urogenital 

Epidemiology. 

Date: June 22, 2010. 

Time: 12 p.m. to 1:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Fungai Chanetsa, MPH, 

PhD, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3135, 

MSC 7770, Bethesda, MD 20892, 301–408– 

9436, fungai.chanetsa@nih.hhs.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Retinopathy 

Studies. 

Date: June 23, 2010. 

Time: 8 a.m. to 5:30 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hyatt Regency Bethesda, One 

Bethesda Metro Center, 7400 Wisconsin 

Avenue, Bethesda, MD 20814. 

Contact Person: Raya Mandler, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5217, 

MSC 7840, Bethesda, MD 20892, 301–402– 

8228, rayam@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ZRG1 

MDCN–N (02): Molecular Neuroscience. 

Date: June 23–24, 2010. 

Time: 8 a.m. to 7 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Virtual Meeting). 


wwoods2 on DSK1DXX6B1PROD with NOTICES
29772 Federal Register / Vol. 75, No. 102 / Thursday, May 27, 2010 / Notices 

Contact Person: Carol Hamelink, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 4192, 

MSC 7850, Bethesda, MD 20892, (301) 213– 

9887, hamelinc@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Health and Related Behaviors of 

Individuals and Populations. 

Date: June 23, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Hilton Alexandria Old Town, 1767 

King Street, Alexandria, VA 22314. 

Contact Person: Karin F. Helmers, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3166, 

MSC 7770, Bethesda, MD 20892, 301–254– 

9975, helmersk@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Non-HIV Anti-Infective 

Therapeutics. 

Date: June 23–24, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: George Washington University Inn, 

824 New Hampshire Avenue, NW., 

Washington, DC 20037. 

Contact Person: Rossana Berti, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3191, 

MSC 7846, Bethesda, MD 20892, 301–402– 

6411, bertiros@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; 

Fellowships: Sensory, Motor, and Cognitive 

Neuroscience. 

Date: June 23, 2010. 

Time: 8 a.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: One Washington Circle Hotel, One 

Washington Circle, NW., Washington, DC 

20037. 

Contact Person: John Bishop, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5182, 

MSC 7844, Bethesda, MD 20892, (301) 408– 

9664, bishopj@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; ARRA: 

Chronic Fatigue Syndrome, Fibromyalgia 

Syndrome, and Temporomandibular Disorder 

Competitive Revisions. 

Date: June 23, 2010. 

Time: 1 p.m. to 2 p.m. 

Agenda: To review and evaluate grant 

applications, 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Lynn E Luethke, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 5166, 

MSC 7844, Bethesda, MD 20892, (301) 806– 

3323, luethkel@csr.nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Member 

Conflicts: Lung Host Defense and Cystic 

Fibrosis Applications. 

Date: June 23, 2010. 

Time: 2 p.m. to 4 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 6701 

Rockledge Drive, Bethesda, MD 20892 

(Telephone Conference Call). 

Contact Person: Everett E Sinnett, PhD, 

Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 2178, 

MSC 7818, Bethesda, MD 20892, 301–435– 

1016, sinnett@nih.gov. 

Name of Committee: Center for Scientific 

Review Special Emphasis Panel; Small 

Business: Risk Prevention and Health 

Behavior. 

Date: June 23–25, 2010. 

Time: 7 p.m. to 5 p.m. 

Agenda: To review and evaluate grant 

applications. 

Place: Pier 5 Hotel, 711 Eastern Avenue, 

Baltimore, MD 21202. 

Contact Person: Claire E. Gutkin, PhD, 

MPH, Scientific Review Officer, Center for 

Scientific Review, National Institutes of 

Health, 6701 Rockledge Drive, Room 3138, 

MSC 7759, Bethesda, MD 20892, 301–594– 

3139, gutkincl@csr.nih.gov. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.306, Comparative Medicine; 

93.333, Clinical Research, 93.306, 93.333, 

93.337, 93.393–93.396, 93.837–93.844, 

93.846–93.878, 93.892, 93.893, National 

Institutes of Health, HHS) 

Dated: May 21, 2010. 

Jennifer Spaeth, 

Director, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2010–12788 Filed 5–26–10; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Healthcare Infection Control Practices 

Advisory Committee, (HICPAC) 

In accordance with section 10(a)(2) of 

the Federal Advisory Committee Act 

(Pub. L. 92–463), the Centers for Disease 

Control and Prevention (CDC) 

announces the following meeting for the 

aforementioned committee: 

Times and Dates: 9 a.m.–5 p.m., June 

17, 2010; 9 a.m.–12 p.m., June 18, 2010. 

Place: CDC, Global Communications 

Center, Building 19, Auditorium B3, 

1600 Clifton Road, NE., Atlanta, Georgia 

30333. 

Status: This meeting is open to the 

public, limited only by the space 

available. Please register for the meeting 

online at http://www.cdc.gov/hicpac or 

by sending an e-mail to hicpac@cdc.gov. 

Purpose: The Committee is charged 

with providing advice and guidance to 

the Secretary, the Assistant Secretary for 

Health, the Director, CDC, and the 

Director, National Center for Emerging 

and Zoonotic Infectious Diseases 

(NCEZID) regarding (1) The practice of 

healthcare infection control; (2) 

strategies for surveillance, prevention, 

and control of infections (e.g., 

nosocomial infections), antimicrobial 

resistance, and related events in settings 

where healthcare is provided; and (3) 

periodic updating of guidelines and 

other policy statements regarding 

prevention of healthcare-associated 

infections and healthcare-related 

conditions. 

Matters to be Discussed: The agenda 

will include: Updates on CDC’s 

activities for healthcare associated 

infections; the draft guideline for the 

Prevention of Norovirus Gastroenteritis 

Outbreaks in Healthcare Settings; the 

draft guideline for prevention of 

infections among patients in neonatal 

intensive care units (NICU); the draft 

guideline for Infection Control in 

Healthcare Personnel; and a discussion 

of infection control in ambulatory care 

settings. 

Agenda items are subject to change as 

priorities dictate. 

Contact Person for More Information: 

Michelle King, HICPAC, Division of 

Healthcare Quality Promotion, National 

Center for Emerging and Zoonotic 

Infectious Diseases, CDC, 1600 Clifton 

Road, N.E., Mailstop A–07, Atlanta, 

Georgia 30333 Telephone (404) 639– 

2936. E-mail: hicpac@cdc.gov. 

The Director, Management Analysis 

and Services Office, has been delegated 

the authority to sign Federal Register 

notices pertaining to announcements of 

meetings and other committee 

management activities, for both CDC 

and the Agency for Toxic Substances 

and Disease Registry. 

Dated: May 19, 2010. 

Elaine L. Baker, 

Director, Management Analysis and Services 

Office, Centers for Disease Control and 

Prevention. 

[FR Doc. 2010–12749 Filed 5–26–10; 8:45 am] 

BILLING CODE 4163–18–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Notice of Meeting 

In accordance with section 10(d) of 

the Federal Advisory Committee Act (5 

U.S.C., Appendix 2), announcement is 

made of a Health Care Policy and 


wwoods2 on DSK1DXX6B1PROD with NOTICES